Immediate and late results of transluminal coronary angioplasty in patients with unstable angina;Angina inestable: Resultados inmediatos y a un año del tratamiento con angioplastía coronaria transluminal percutánea

Revista Medica de Chile

Volumn 126, Issue 11, 1998, Pages 1338-1344

  Marchant D, Eugenio ^a,b   Martínez S, Alejandro ^a   Fajuri N, Alejandro ^a   Guarda S, Eduardo ^a  

^a Rheumatology Service   (Chile)

^b NONE   (Chile)

Author keywords

Angina, unstable; Angioplasty, balloon; Coronary disease; Myocardtal revascularization

Indexed keywords

ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 3242824947     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. FUSTER V, CHESEBHO JW. Mechanisms of unstable angina. N Engl J Med 1986; 315: 1023-5.
2. AMBROSE JA, WINTERS SL, ARORA RR, ENG A, RICCIO A, GORLIN R ET AL. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coil Cardiol 1986; 7: 472-8.
3. FORRESTER JS, LITVACK F, GRUNDFEST W, HICKEY A. A perspective of coronary disease seen through the arteries of living man. Circulation, 1987; 75: 505-13.
4. THEROUX P, WATERS D, QIU S, MC CANS J, DE GUISE P, JUNEAU M ET AL. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1994; 88: 2045-8.
5. FIGUERAS J, LIDON R, CORTADELLAS J. Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglicerin infusion in patients with unstable angina at rest. Eur Heart J 1991; 12: 405-11.
6. YUSUF S, WITTER J, FRIEDMAN L. Overview of results of randomized clinical trials in heart disease. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988; 260: 2259-63.
7. THE TIMI III B INVESTIGATORS. Effects of Tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994; 89: 1545-56.
8. WILLIAMS DO, BRAUNWALD E, THOMPSOM B, SHARAF B, BULLER CH, KNATTERUD G ET AL. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave mycardial infarction. Observations from the TIMI III B Trial. Circulation 1996; 94: 2749-55.
9. RYAN TJ, BAUMAN WB, KENNEDY JW, KEREIAKES DK, KING SB III, MC CALLISTER BD, ET AL. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology. American Heart Association Task force on Assessment of diagnostic and therapeutic cardiovascular procedures. Circulation 1988; 78: 486-502.
10. WILLIAMS DO, RILEY RS, SINGH AK, GEWIRTZ H, MOST AS. Evaluation of the role of coronary angioplasty in patients with unstable angina pectoris. Amer Heart J 1981; 102: 1-9.
11. FREEMAN ML, WILLIAMS AE, CHISHOLM RJ, ARMSTRONG PW. Intracoronary trombus and complex morphology in unstable angina. Relation to timing of angiography and in hospital cardiac events. Circulation 1989; 80: 17-23.
12. AMBROSE JA, WINTERS SL, ARORA RR, HAFT J, GOLDSTEIN J, RENTROP KP ET AL. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985; 6: 1233-8.
13. DE FEYTER PJ, OZAKI Y, BAPTISTA J, ESCANED J, DI MARIO C, DE JAEGERE P ET AL. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 1995; 92: 1408-13.
14. NERI SERNERI GG, PRISCO D, MARTINI F, GORI A, BRUNELLI A, POGGESI L ET AL. Acute T-cell activation is detectable in unstable angina. Circulation 1997; 95: 1806-12.
15. VAN DER WAL AC, BACKER AE, VAN DER LOOS CM, DAS PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
16. RICHARDSON PD, DAVIES MJ, BORN GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet, 1989; 2: 941-4.
17. BENTIVOGLIO LG, DETRE KM, YEH W, WILLIAMS DO, KELSEY SF, FAXON DP. Outcome of percutaneous transluminal coronary angioplasty in subjects of unstable angina pectoris: a report from 1985-1986 National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol 1994; 24: 1195-206.
18. HOLMES DR, FAXON DP, KENT KM, BENTIVOGLIO LG, DETRE K AND THE COINVESTIGATORS OF THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY REGISTRY. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981, and from 1985 to 1986: The National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol 1988; 12: 1149-55.
19. STAMMEN F, DE SCHEERETER I, GLAZIER JJ, VAN LIERDE J, VROLIX M, WILLEMS JL ET AL. Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris. Am J Cardiol 1992; 69: 1533-7.
20. MYLER RK, SHAW RE, STERTZER SH, BASHOUR TT, RYAN C, HECHT HS, CUMBERLAND DC. Unstable angina and coronary angioplasty. Circulation 1990; 82 (suppl II): 11-88.
21. MORRISON DA. Percutaneous transluminal coronary angioplasty for rest angina pectoris requiring intravenous nitroglycerin and intra-aortic balloon counterpulsation. Am J Cardiol 1990; 66: 168.
22. THE RISC GROUP. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30.
23. HETTLEMAN DD, APLIN RA AND SULLIVAN PR. Three days of heparin pretreatment reduces major complications of coronary angioplasty in patients with unstable angina (abstr). J Am Coll Cardiol 1990, 15: 154.
24. LASKEY MA, DEUTSCH E, HIRSCHFELD JW, KUSSMAUL WG, BARNATHAN E, LASKEY WK. Influence of heparin on percutaneous trasluminal coronary angioplasty out come in patients with coronary arterial thrombus. Am J Cardiol 1990; 65: 179-84.
25. LINCOFF AM, CALIFF RM, ANDERSON KM, WEISMAN HF, AGUIRRE F, KLEIMAN H ET AL. Evidence for prevention of death and myocardial infarction with platelet membrana glycoprotein IIb/IIIa receptor blockade by Abciximab (C7 E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1997; 30: 149-56.
26. SIMPFENDORFER C, KOTTKE-MARCHANT K, LOWRIE M, ANDERS RJ, BURNS D, MILLER D, COVE C ET AL. First chronic platelet glycoprotein IIb/IIIa integrin blackade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions. Circulation 1997; 96: 76-81.
27. WEINTRAUB WS, WENGER NK, KOSINSKI AS, DOUGLAS JS JR, LIBERMAN HA, MORNES DC, ET AL. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol 1994; 24: 81-90.
28. RUPPRECHT MJ, BRENNECKE R AND KOTTMEYER M. Short and long-term outcome after PTCA in patients with stable and unstable angina. Eur Heart J 1990; 11: 964-8.
29. DE FEYTER PJ AND SERRUYS PW. Unstable angina. Role of coronary interventies. In Fuster V, Ross R and Topol EJ (eds): Atherosclerosis and Coronary Artery Disease. Philadelphia. Lippincott-Raven, 1996, 1351-8.
30. TALLEY JD, HURST SW, KING SB, DOUGLAS JS, ROUBIN GS, GRUENTZIG AR ET AL. Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty in 427 patients. Circulation 1988; 77: 820-6.
31. ANDERSON HV, CANNON CP, STONE PH, WILLIAMS DO, MC CABE CH, KNATTERUD GL ET AL. One-Year results of the thrombolysis in myocardial infarction (TIMI) III B clinical trial. J Amer Coll Carding 1995; 26: 1643-50.